CervoMed CRVO
NASDAQ CRVO
$2.60 +0.04 (+1.54%)
As of: Aug 21, 2026 · 1:28 PM EDT

CervoMed (CRVO) Receivables - Net (2011 - 2025)

CervoMed (CRVO) posted Receivables - Net of $426993.0 for Q4 2025, down 68.64% sequentially from $1.4 million in Q3 2025, and down 81.06% YoY from $2.3 million in Q4 2024.

CervoMed (CRVO) Receivables - Net (2011 - 2025) Analysis & Trends

CervoMed has reported Receivables - Net for 6 years, with the latest figure at $426993.0 in Q4 2025.

  • Quarterly Receivables - Net fell 81.06% year-over-year to $426993.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $426993.0 (down 81.06% YoY) and the FY2025 annual result came in at $426993.0, down 81.06% from the prior year.
  • Receivables - Net slipped to $426993.0 in Q4 2025 per CRVO's latest filing, from $1.4 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $2.4 million in Q2 2025 and troughed at $264148.0 in Q3 2024.
  • A 3-year average of $1.3 million and a median of $1.4 million in 2025 frame the typical range for Receivables - Net.
  • The widest YoY moves for Receivables - Net: up 415.39% in 2025, down 81.06% in 2025.
  • Over 3 years, Receivables - Net stood at $915404.0 in 2023, then soared by 146.26% to $2.3 million in 2024, then tumbled by 81.06% to $426993.0 in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods registered $426993.0, $1.4 million, and $2.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.35 Bn 131.50 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.12 Bn 78.12 Bn 3.93 Bn
3 Argenx Se 65.22 Bn 60.03 Bn 1.37 Bn
4 Moderna 58.98 Bn 53.84 Bn 52.00 Mn
5 BeOne Medicines 42.08 Bn 36.99 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.61 Bn 28.30 Bn 992.69 Mn
7 BioNTech SE 27.98 Bn 9.59 Bn 668.28 Mn
8 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
9 Royalty Pharma 27.30 Bn 26.47 Bn -
10 CervoMed 26.64 Mn 26.64 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 426,993.00
Dec 31, 2025 426,993.00
Sep 30, 2025 1.36 Mn
Sep 30, 2025 1.36 Mn
Jun 30, 2025 2.36 Mn
Jun 30, 2025 2.36 Mn
Mar 31, 2025 1.63 Mn
Mar 31, 2025 1.63 Mn
Dec 31, 2024 2.25 Mn
Dec 31, 2024 2.25 Mn
Sep 30, 2024 264,148.00
Sep 30, 2024 264,148.00
Dec 31, 2023 915,404.00
Dec 31, 2023 915,404.00
Dec 31, 2013 684,742.00
Dec 31, 2013 684,742.00
Sep 30, 2013 735,735.00
Sep 30, 2013 735,735.00
Jun 30, 2013 741,415.00
Jun 30, 2013 741,415.00